ERBB2 and triple-negative breast carcinoma: In conclusion, the present study provided an evidence of the synergistic anticancer effect of ω-3 FFAs and ATRA on ER-positive, HER2-positive and triple negative breast cancer cells (MCF7, SK-BR-3, HCC2806 and MDA-MB-231) via induction of cell cycle arrest and apoptotic cell death.